MWA
ABBV icon

MN Wealth Advisors’s AbbVie ABBV Stock Holding History

MN Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$518K Sell
2,059
-229
-10% -$49.3K 0.22% 74
2026
Q1 		$498K Buy
2,288
+98
+4% +$21.7K 0.24% 73
2025
Q4 		$501K Buy
2,190
+43
+2% +$9.79K 0.25% 67
2025
Q3 		$497K Buy
2,147
+144
+7% +$29.3K 0.27% 70
2025
Q2 		$372K Buy
2,003
+13
+0.7% +$2.42K 0.22% 84
2025
Q1 		$417K Buy
1,990
+30
+2% +$5.83K 0.24% 72
2024
Q4 		$348K Buy
1,960
+190
+11% +$34.9K 0.2% 74
2024
Q3 		$350K Sell
1,770
-63
-3% -$11.8K 0.2% 74
2024
Q2 		$314K Buy
1,833
+82
+5% +$13.6K 0.18% 79
2024
Q1 		$319K Buy
1,751
+56
+3% +$9.65K 0.2% 75
2023
Q4 		$263K Buy
+1,695
New +$247K 0.18% 75

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MN Wealth Advisors's ABBV Position: Q2 2026 in Review

MN Wealth Advisors reduced its AbbVie (ABBV) stake by 10% in Q2 2026, selling an estimated $49.3K and leaving 2,059 shares worth $518K. The position accounts for 0.22% of the portfolio, ranked #74.

MN Wealth Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MN Wealth Advisors held 2,059 shares of AbbVie worth $518K as of Q2 2026.
  • MN Wealth Advisors sold 229 AbbVie shares in Q2 2026, an estimated $49.3K.
  • AbbVie made up 0.22% of MN Wealth Advisors's portfolio in Q2 2026, its #74 holding.
  • MN Wealth Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MN Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.